Amrep (AXR) Cash & Equivalents (2010 - 2026)

Amrep has disclosed Cash & Equivalents across 17 years of filings, most recently posting $50.5 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $50.5 million, up 35.04% year-over-year; the trailing twelve-month figure through Jan 2026 was $50.5 million (up 35.04% YoY), and the FY2025 annual result was $39.9 million, up 32.01% from the prior year.
• Cash & Equivalents came in at $50.5 million for Q1 2026 at Amrep, up from $45.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $50.5 million in Q1 2026 to a low of $12.4 million in Q1 2023.
• The 5-year median for Cash & Equivalents is $27.3 million (2022), against an average of $29.1 million.
• Across the five-year window, Cash & Equivalents tumbled 57.5% in 2022 and soared 142.97% in 2024, its largest moves.
• Amrep's Cash & Equivalents stood at $12.9 million in 2022, then gained by 29.74% to $16.7 million in 2023, then jumped by 142.97% to $40.6 million in 2024, then climbed by 11.04% to $45.1 million in 2025, then gained by 11.93% to $50.5 million in 2026.
• The last three Cash & Equivalents figures came in at $50.5 million (Q1 2026), $45.1 million (Q4 2025), and $49.4 million (Q3 2025), per Business Quant data.